Back to Journals » Vascular Health and Risk Management » Volume 12

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Total article views   Abstract views HTML views PDF downloads Totals
11,475 Dovepress* 5,605 2,699+ 1,676 8,304
PubMed Central* 0 3,171 994 3,171
Totals 5,605 5,870 2,670 11,475
*Since 9 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar